GeneDx director acquires 1,146 shares via RSUs
GeneDx Holdings Corp. (WGS) director Thomas Fuchs reported the settlement of 1,146 Restricted Stock Units into 1,146 shares of Class A Common Stock on September 17, 2026, for no cash consideration.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
GeneDx Holdings Corp. (WGS) director Thomas Fuchs reported the settlement of 1,146 Restricted Stock Units into 1,146 shares of Class A Common Stock on September 17, 2026, for no cash consideration. After these transactions, he holds 1,146 common shares and 2,292 RSUs directly. No Rule 10b5-1 trading plan is reported.
Insider Trade Summary
1,146 shares exercised/converted
Exercise
2 txns
Insider
Fuchs Thomas
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F2 | 1,146 | $0.00 | $0.00 |
| Exercise | Class A Common Stock F1 | 1,146 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Unit — 2,292 contracts (Direct);
Class A Common Stock — 1,146 shares (Direct)
Footnotes (2)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- F2. The award shall vest in three equal installments on September 17, 2026, September 17, 2027, and September 17, 2028, subject to the reporting person's continued service to the Issuer on the applicable vesting date.
Key Figures
RSUs converted: 1,146 units
Shares acquired: 1,146 shares
Common shares held after transaction: 1,146 shares
+2 more
5 metrics
RSUs converted
1,146 units
Restricted Stock Units settled into Class A Common Stock on September 17, 2026
Shares acquired
1,146 shares
Class A Common Stock received upon RSU settlement on September 17, 2026
Common shares held after transaction
1,146 shares
Direct holdings of Class A Common Stock after reported transactions
RSUs held after transaction
2,292 units
Direct Restricted Stock Unit holdings following the conversions
RSU vesting schedule
3 equal installments
Vesting on September 17, 2026, 2027, and 2028, subject to continued service
Key Terms
Restricted Stock Unit, Class A Common Stock, contingent right, vesting
4 terms
Restricted Stock Unit financial
"Each restricted stock unit ("RSU") represents a contingent right to receive 1 share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Class A Common Stock financial
"1 share of the Issuer's Class A Common Stock upon settlement for no consideration"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
contingent right financial
"represents a contingent right to receive 1 share of the Issuer's Class A"
vesting financial
"The award shall vest in three equal installments on September 17, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did director Thomas Fuchs report at GeneDx Holdings Corp. (WGS)?
He reported the exercise and settlement of 1,146 Restricted Stock Units into 1,146 shares of Class A Common Stock on September 17, 2026, with a reported price of $0.00 per share, reflecting no cash consideration for the conversion.
How many Restricted Stock Units does Thomas Fuchs still hold in GeneDx (WGS)?
Following the September 17, 2026 transactions, Thomas Fuchs directly holds 2,292 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Class A Common Stock upon settlement for no consideration.
What are the vesting terms for Thomas Fuchs’s GeneDx (WGS) RSU award?
The RSU award is scheduled to vest in three equal installments on September 17, 2026, September 17, 2027, and September 17, 2028, subject to his continued service to GeneDx Holdings Corp. on each applicable vesting date.
Was Thomas Fuchs’s GeneDx (WGS) Form 4 transaction under a Rule 10b5-1 plan?
No. The filing indicates that no Rule 10b5-1 trading plan is reported in connection with these transactions by director Thomas Fuchs.
AI-generated analysis. How Rhea-AI works. Not financial advice.
